AI-Powered ASX Trading Signals

Real-time insights. Smarter decisions. Better trades.

🔍 Search Stocks 14 day Free Trial

ARGENICA THERAPEUTICS LIMITED (AGN)


AI Coverage Rating: Moderate

ASX AI Signals has generated 2 signal(s) for AGN during the last 90 days, indicating Moderate trading activity

Latest AGN Signals

25/06/2026SELL
08/05/2026SELL

AGN Share Price

Current Price$0.120
52 Week High$0.730
52 Week Low:$0.090
Trading at (% of 52 Week High) 16.44%


Volume 240776
20 Day Avg 587431
Relative Volume 41.0%


Business Overview

Argenica Therapeutics Limited (ASX: AGN) is a biotechnology company focused on developing innovative therapies for cancer and other serious diseases. The company specializes in targeted treatments using its proprietary technology platforms to improve patient outcomes.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The SELL recommendation for ARGENICA THERAPEUTICS LIMITED (AGN) is supported by the current low stock price indicating potential undervaluation concerns, combined with market signals pointing to downward momentum. However, the confidence is moderated by limited publicly available financial data and potential volatility in the biotech sector.

Latest  ARGENICA THERAPEUTICS LIMITED(AGN)   News

06 May 2025, 06:02 AM

ASX Penny Stock Highlights For May 2025

The Australian stock market recently experienced a downturn, with the ASX200 closing down 0.97% at 8,157 points, and sectors like Energy and Financials leading the decline. Despite these broader market challenges, penny stocks continue to capture investor interest due to their potential for signific

Unlock All ASX AI Signals

Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.

14 Day Free Trial • Cancel Anytime • Founders Price $15/month

Start My Free Trial